Seattle Genetics, Astellas, Merck & Co. collaborate to study enfortumab + Keytruda in bladder cancer Dec. 3, 2019
Neurocrine Biosciences and Xenon collaborate to develop first-in-class treatments for epilepsy Dec. 3, 2019
Akari announces trial design for pivotal phase III study of nomacopan in pediatric HSCT-TMA Dec. 3, 2019
RSS